跳至主要内容
临床试验/CTRI/2020/03/023958
CTRI/2020/03/023958尚未招募未知

Roll of toll-like receptors and TLR agonists in modulating response to chemotherapy in TNBC patients.

Department of Biotechnology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patient Selection:
  • a)Histopathologically proven TNBC
  • b)Age >18 years
  • c)Non-metastatic
  • d)No prior surgery or treatment for breast cancer or any other non-skin cancer
  • e)Undergoing surgery first
  • f)Planned for NACT fit to receive chemotherapy (Normal RFT LFT Hematological parameters 2D ECHO)
  • g)ECOG 0to1
  • h)Written, informed consent
  • Inclusion criteria for healthy female controls:
  • a)Age >18 years
  • b)Non-pregnant, non-lactating
  • c)No current or past or family history of malignancy
  • d)No h/o autoimmune disorder
  • e)Malignancy screen negative (oral, clinical breast and per vaginal examination SOS mammography, Visual Inspection with Acetic Acid (VIA) or PAP smear negative in last 3 yrs)
  • f)Written, informed consent

排除标准

  • Exclusion Criteria:
  • a)Pregnant, lactating
  • b)Previous treatment for breast cancer or any other non-skin cancer
  • c)h/o autoimmune disorder
  • d)Viral markers (HBsAg, HCV, HIV) positive

研究者

发起方
Department of Biotechnology

相似试验